YWHAZ amplification/overexpression defines aggressive bladder cancer and contributes to chemo‐/radio‐resistance by suppressing caspase‐mediated apoptosis

Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways

(2018) Mathieu Rouanne et al.   WORLD JOURNAL OF UROLOGY

Bacillus Calmette–Guérin and anti-PD-L1 combination therapy boosts immune response against bladder cancer

(2018) Yonghua Wang et al.   OncoTargets and Therapy

Hyperprogressive disease: recognizing a novel pattern to improve patient management

(2018) Stéphane Champiat et al.   Nature Reviews Clinical Oncology

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets

(2017) Eugene J. Pietzak et al.   EUROPEAN UROLOGY

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

(2017) Sebastien Antoni et al.   EUROPEAN UROLOGY

Knockdown of PYCR1 inhibits cell proliferation and colony formation via cell cycle arrest and apoptosis in prostate cancer

(2017) Tengyue Zeng et al.   MEDICAL ONCOLOGY

Genetics: A clearer view

(2017) Jeanne Erdmann   NATURE

The evolving genomic landscape of urothelial carcinoma

(2017) Alexander P. Glaser et al.   Nature Reviews Urology

Roles of Rap1 signaling in tumor cell migration and invasion

(2017) Zhang Yi-Lei et al.   Cancer Biology & Medicine

Innate immune signaling and regulation in cancer immunotherapy

(2016) Leticia Corrales et al.   CELL RESEARCH

Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1

(2016) Stéphane Champiat et al.   CLINICAL CANCER RESEARCH

Tumour-specific proline vulnerability uncovered by differential ribosome codon reading

(2016) Fabricio Loayza-Puch et al.   NATURE

Innate Immune Recognition of Cancer

(2015) Seng-Ryong Woo et al.   Annual Review of Immunology

14-3-3ζ Turns TGF-β’s Function from Tumor Suppressor to Metastasis Promoter in Breast Cancer by Contextual Changes of Smad Partners from p53 to Gli2

(2015) Jia Xu et al.   CANCER CELL

Ser9-phosphorylated GSK3β induced by 14-3-3ζ actively antagonizes cell apoptosis in a NF-κB dependent manner

(2014) Xuejuan Gao et al.   Biochemistry and Cell Biology

Metabolic Vulnerabilities in Endometrial Cancer

(2014) F. L. Byrne et al.   CANCER RESEARCH

Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma

(2014) M. Riester et al.   CLINICAL CANCER RESEARCH

Metabolic-Stress-Induced Rearrangement of the 14-3-3  Interactome Promotes Autophagy via a ULK1- and AMPK-Regulated 14-3-3  Interaction with Phosphorylated Atg9

(2014) V. K. Weerasekara et al.   MOLECULAR AND CELLULAR BIOLOGY

Comprehensive molecular characterization of urothelial bladder carcinoma

(2014)   NATURE

Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma

(2013) Y Nishimura et al.   BRITISH JOURNAL OF CANCER

αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma

(2013) Xiao-Yong Huang et al.   HEPATOLOGY

Somatic copy number alterations by whole-exome sequencing implicatesYWHAZandPTK2in castration-resistant prostate cancer

(2013) Roopika Menon et al.   JOURNAL OF PATHOLOGY

14-3-3 , a Novel Androgen-Responsive Gene, Is Upregulated in Prostate Cancer and Promotes Prostate Cancer Cell Proliferation and Survival

(2012) T. Murata et al.   CLINICAL CANCER RESEARCH

A Novel Function of YWHAZ/ -Catenin Axis in Promoting Epithelial-Mesenchymal Transition and Lung Cancer Metastasis

(2012) C.-H. Chen et al.   MOLECULAR CANCER RESEARCH

Silencing of 14-3-3ζ over-expression in hepatocellular carcinoma inhibits tumor growth and enhances chemosensitivity to cis-diammined dichloridoplatium

(2011) Jung Eun Choi et al.   CANCER LETTERS

Talin-1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis

(2011) Ming-Tsung Lai et al.   JOURNAL OF PATHOLOGY

Post-translational modification of 14-3-3 isoforms and regulation of cellular function

(2011) Alastair Aitken   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

14-3-3ζ as a prognostic marker and therapeutic target for cancer

(2010) Christopher L Neal et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer

(2010) Yang Li et al.   NATURE MEDICINE

14-3-3ζ Cooperates with ErbB2 to Promote Ductal Carcinoma In Situ Progression to Invasive Breast Cancer by Inducing Epithelial-Mesenchymal Transition

(2009) Jing Lu et al.   CANCER CELL

Functional Genomic Analysis Identified Epidermal Growth Factor Receptor Activation as the Most Common Genetic Event in Oral Squamous Cell Carcinoma

(2009) J. J.-C. Sheu et al.   CANCER RESEARCH

Control of cell adhesion dynamics by Rap1 signaling

(2009) Benjamin Boettner et al.   CURRENT OPINION IN CELL BIOLOGY

Metabolic Control of Oocyte Apoptosis Mediated by 14-3-3ζ-Regulated Dephosphorylation of Caspase-2

(2009) Leta K. Nutt et al.   DEVELOPMENTAL CELL

Copy number gain and oncogenic activity of YWHAZ/14-3-3ζ in head and neck squamous cell carcinoma

(2009) Mauting Lin et al.   INTERNATIONAL JOURNAL OF CANCER